Prevención no farmacológica de la neumonía asociada a ventilación mecánica |
| |
| Authors: | Luis Aurelio Dí az,Mireia Llauradó ,Jordi Rello,Marcos I. Restrepo |
| |
| Affiliation: | 1. Geisinger Health System, Danville, Pensilvania, EE.UU.;2. CIBER de Enfermedades Respiratorias (CibeRes), Hospital Universitario Joan XXIII, Tarragona, España;3. Institut d’Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, Tarragona, España;4. VERDICT, South Texas Veterans Health Care System Audie L. Murphy Division, University of Texas Health Science Center at San Antonio, Division of Pulmonary and Critical Care Medicine, San Antonio, Texas, EE.UU. |
| |
| Abstract: | Ventilator-associated pneumonia (VAP) is the first cause of mortality due to nosocomial infections in the intensive care unit. Its incidence ranges from 9% to 67% of patients on mechanical ventilation. Risk factors are multiple and are associated with prolonged stays in hospital and intensive care units. Additional costs for each episode of VAP range from 9,000 € to 31,000 €. |
| |
| Keywords: | Neumoní a asociada a ventilació n mecá nica Respiració n artificial Infecció n hospitalaria Unidad de cuidados intensivos Prevenció n de enfermedades |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
